Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cell Host Microbe ; 29(12): 1828-1837.e5, 2021 12 08.
Artigo em Inglês | MEDLINE | ID: mdl-34784508

RESUMO

Developing new influenza vaccines with improved performance and easier administration routes hinges on defining correlates of protection. Vaccine-elicited cellular correlates of protection for influenza in humans have not yet been demonstrated. A phase-2 double-blind randomized placebo and active (inactivated influenza vaccine) controlled study provides evidence that a human-adenovirus-5-based oral influenza vaccine tablet (VXA-A1.1) can protect from H1N1 virus challenge in humans. Mass cytometry characterization of vaccine-elicited cellular immune responses identified shared and vaccine-type-specific responses across B and T cells. For VXA-A1.1, the abundance of hemagglutinin-specific plasmablasts and plasmablasts positive for integrin α4ß7, phosphorylated STAT5, or lacking expression of CD62L at day 8 were significantly correlated with protection from developing viral shedding following virus challenge at day 90 and contributed to an effective machine learning model of protection. These findings reveal the characteristics of vaccine-elicited cellular correlates of protection for an oral influenza vaccine.


Assuntos
Imunidade , Vacinas contra Influenza/imunologia , Influenza Humana/imunologia , Vacinação , Método Duplo-Cego , Humanos , Imunidade Celular , Imunização , Vírus da Influenza A Subtipo H1N1 , Vírus da Influenza A , Influenza Humana/prevenção & controle , Selectina L/metabolismo , Fator de Transcrição STAT5/metabolismo , Linfócitos T , Vacinas de Produtos Inativados/imunologia , Eliminação de Partículas Virais
2.
J Reprod Med ; 53(4): 299-301, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18472655

RESUMO

BACKGROUND: Recurrent vulvar lymphangitis secondary to pelvic lymphadenectomy and radiation therapy can be a vexing clinical dilemma. CASE: A 55-year-old woman was initially treated with radical hysterectomy and 1 postoperative radiotherapy for cervical carcinoma in 1984. In 1987 she developed persistent vulvar, leg, and ankle edema; chronic vulvar pain; and recurrent vulvar cellulitis, which were ultimately attributed to group B Streptococcus. Despite long-term antibiotic therapy and compression stockings, the cellulitis was intractable. In June 2006 the patient underwent a bilateral simple vulvectomy with preservation of the clitoris and insertion of bilateral subcutaneous Jackson-Pratt drains. Her postoperative culture results revealed normal vaginal flora. CONCLUSION: The patient's wounds healed very well, and she has had no further episodes of vulvitis or lymphangitis. The management of recurrent infections involving lymphedema can be difficult and cause complicated clinical issues.


Assuntos
Linfangite/cirurgia , Vulva/cirurgia , Doenças da Vulva/cirurgia , Carcinoma/terapia , Celulite (Flegmão)/microbiologia , Celulite (Flegmão)/cirurgia , Feminino , Humanos , Excisão de Linfonodo , Pessoa de Meia-Idade , Radioterapia Adjuvante/efeitos adversos , Recidiva , Infecções Estreptocócicas/complicações , Infecções Estreptocócicas/terapia , Streptococcus agalactiae , Neoplasias do Colo do Útero/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA